The influence of nine newly synthesized uracil acyclonucleosides, and 36 derivatives of 1,2,3,4-tetrahydroisoquinoline on the activity of enzymes catalysing dTMP and dGMP synthesis, on the content of dTTP and dGTP in acid soluble fraction and on the incorporation of [ 1-(4-chlorophenyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (3), 1-(2,3-dichlorophenyl)-6,7-dihydroxy 1,2,3,4-tetrahydroisoquinoline (4) and 1-(3-methoxyphenyl)-6,7-dihydroxy 1,2,3 ,4-tetrahydroisoquinoline (5) at 0.2 mM concentration caused a mixed type inhibition of the synthesis of dTMP and dGMP by, on average, 33.2±4.4%, and reduced the content of dTTP and dGTP in the acid soluble fraction (52.6±3.7% of control) but were active only in the cytosol of neurofibrosarcoma. While acyclonucleosides undergo
In this paper we present a continuation of our study on compounds exhibiting cytostatic properties. Previously we have found that alkoxymethyl purine and pyrimidine acyclonucleosides tested on experimental tumours (Kirkman-Robbins hepatoma, amelanotic melanoma) inhibit tumour growth, the synthesis of dAMP, dGMP and dTMP, and the incorporation of dNTP into DNA (Greger & Dramiński, 1989; Modrzejewska et al., 1996; 1999) . The results presented herein concern 45 newly synthesized compounds. Nine of them are acyclonucleoside (ACN) uracil derivatives and 36 are tetrahydroisoquinoline (THI) derivatives. The inclusion of THI derivatives has resulted from the fact that these compounds, apart from other properties, exhibit also cytostatic activity (Lin M-C et al., 1995; Goldbrunner et al., 1997) . Among the investigated compounds two ACN derivatives (Fig. 1 , comp. 1, 2) and three THI derivatives (Fig. 1, comp. 3, 4 and 5) reveal moderate biological activity. Compounds 6 and 7 are hardly biologically active; the reason of their inclusion in the study will be explained in the Results and Discussion. The study on the biological properties of the ACN and THI derivatives were carried out on intraoperatively obtained human tumours -neurofibrosarcoma and ovarian cancer. Determination of dTMP synthesized by dThd kinase enabled the assessment of this enzyme activity. dGMP synthesis served to evaluate dCyd kinase activity, as dGuo and not dCyd is the preferred substrate of this enzyme (Usova & Eriksson, 1997) . dGuo kinase occurs mainly in mitochondria (Wang et al., 1993; Jullig & Eriksson, 2001 ) dCyd kinase is responsible for the synthesis of dGMP in the cytosol (Arner & Eriksson, 1995) . Apart from the determination of the activities of both kinases which were subject to the effect of active forms of ACNs and THIs, we studied the content of dTTP and dGTP in the acid soluble fraction obtained from tumour homogenates, the phosphorylation of ACNs and THIs catalysed by kinases present in the cytosol of the tumours and also the incorporation of hexamethyldisilazane (HMDS) was refluxed for 3 h to dissolve uracil. The solvent was evaporated to viscous oil and equimolar amount of 1-benzyloxy-3-chloropropane was added. The mixture was kept overnight at room temperature. The reaction was monitored by TLC and the mixture was coevaporated with ethanol and with ammonia so-lution in ethanol. The residue was crystallised twice from ethanol. The yield of 1-N-(3¢-hydroxypropyl)-6-methyluracil was 1.5 g (45%). -hydroxypropyl)-5,6-tetramethyleneuracil (2): 5,6-tetramethyleneuracil (3.32 g, 20 mmol) 3-N-(3¢-hydroxypropyl)-5,6-tetramethyleneuracil (7) : 0.48 g (2 mmol) 3-N-(3¢-hydroxypropyl)-5,6-tetramethylene-2-thio uracil in 5 cm 3 10% solution of chloroacetic acid was refluxed for 10 h to give 50% yield of 3-N-(3¢-hydroxypropyl)-5,6-tetramethyleneuracil.
1-N-(3¢
Analytical data of the synthesized acycyclonucleosides are shown in Table 1 . Biologically active THI derivatives were synthesized by Brzezińska (1996) and analytical data of these compounds were described in the mentioned paper.
Biology
Chemical and enzyme assays. Tumours (5-6 g) obtained intraoperatively were immediately homogenized at 0 o C in a Potter-Elve-
hjem apparatus in 20-24 ml of 25 mM Tris/HCl buffer (pH 7.4) containing 250 mM sucrose, 25 mM KCl and 5 mM MgCl 2 (medium A). Nuclei and mitochondria were spun down at 10 000´g for 20 min and the resulting supernatant, after centrifugation at 105 000´g for 60 min representing the cytosol was used for the experiments. dThd and dCyd kinase activities were assayed as described previously (Greger & Dramiński, Vol. 50 Acyclonucleosides and 1,2,3,4-tetrahydroisoquinoline derivatives 1177 
) in the cytosol of neurofibrosarcoma (A) and ovarian cancer (B).
Each value: mean ± S.D. for four separate experiments. P values, after checking variance conformability using Fisher-Snedecor test, were calculated using Student's t-test. In parentheses % of inhibition. NS, the difference non significant. fraction obtained according to Letnansky (1964) 
RESULTS AND DISCUSSION
Biologically active 0.2 mM ACNs and THIs inhibit the synthesis of dTMP and dGMP to an identical level (ACN 34 ± 4%, THI 33 ± Vol. 50
Acyclonucleosides and 1,2,3,4-tetrahydroisoquinoline derivatives 1179 (Fig. 1, comp. 1, 2) and THI (Fig. 1, comp. 3, 4 and 5) derivatives.
4.4% inhibition,
A, neurofibrosarcoma dThd kinase, (l, r 2 = 0.92), comp. 1 (Ñ , r 2 = 0.99), and 2 (n, r 2 = 0.98); B, neurofibrosarcoma dCyd kinase, (l, r 2 = 0.92), comp. 1 (Ñ , r 2 = 0.96), and 2 (n, r 2 = 0.97); C, ovarian cancer dThd kinase, (l, r 2 = 0.84), comp. 1 (Ñ , r 2 = 0.98), and 2 (n, r 2 = 0.99); D, ovarian cancer dCyd kinase, (l, r 2 = 0.92), comp. 1 (Ñ , r 2 = 0.91), and 2 (n, r 2 = 0.96); E, neurofibrosarcoma dThd kinase, (l, r 2 = 0.81), comp. 3 (t, r 2 = 0.97), comp. 4 (o, r 2 = 0.97) and 5 (s, r 2 = 0.98); F, neurofibrosarcoma dCyd kinase, (l, r 2 = 0.78), comp. 3 (t, r 2 = 0.94), and 5 (s, r 2 = 0.94). K m calculated from these plots equals: neurofibrosarcoma dThd kinase 51.2 mM, dCyd kinase 41.6 mM. Ovarian cancer: dThd kinase 53,7 mM, dCyd kinase 71,4 mM. K mi values calculated from these plots are: neurofibrosarcoma dThd kinase comp. 1, 2, 3, 4 and 5: 1.8, 1.5, 1.2, 1.07, 1.3´10 -4 M, respectively; dCyd kinase comp. 1, 2, 3 and 5: 1.5, 1.9, 1.1 10 -4 M, 9.6´10 -5 M, respectively. Ovarian cancer dThd kinase, comp. 1 and 2: 1.5, 1.6´10 -4 M respectively; dCyd kinase, comp. 1 and 2: 9.8, 1.2´10 -4 M, respectively. K i values included in Table 2 (Table 2) as well as active THIs 3, 4 and 5. Changes in the enzyme activity in the presence of ACN derivatives point to a competitive type of inhibition of the enzyme by these compounds, while THI derivatives inhibit the enzyme in a mixed way. The inhibition of dGMP synthesis by active THI derivatives 3 and 5 in neurofibrosarcoma (Table 2) is also of a mixed character. This fact may be explained by a greater K i value for THI where, unlike in competitive inhibition, the inhibitor binds both the free enzyme as well as the enzyme-substrate complex. Table 2 comprises aditionally a set of characteristics of two ACN derivatives 6 and 7. They exhibit only 5% of the activity of compounds 1 and 2, but they were subsequently used for the explanation of active ACNs biotransformation. A loss of the inhibitory properties of ACN derivatives 1 and 2 in the presence of EDTA and a complete lack of this effect in the presence of ACN derivatives 6 and 7 and THI derivatives 3, 4 and 5 suggest a possibly different ACN and THI metabolism. This suggestion is confirmed by the results of ACN and THI phosphorylation presented in Table 3 . Biologically active ACNs undergo phosphorylation to corresponding triphosphates by deoxynucleoside 5'-mono and 5'-diphosphate kinases present in the cytosol of both tumours. The extent of phosphorylation to the corresponding triphosphates of derivatives 1, 2, 6 and 7 is the same but the resulting amounts of ACN triphosphates of derivatives 6 and 7 is 20-fold lower than triphosphate derivatives 1 and 2. Both the above mentioned facts and the almost complete lack of inhibitory activity of derivatives 6 and 7 (Table 2 ) allow one to presume that ACN triphosphates are the inhibitors of dThd and dCyd kinases in neurofibrosarcoma and ovarian cancer. Another confirmation of this inference is the behaviour of active ACNs in the presence of EDTA. While inhibiting the activity of deoxynucleoside 5¢-diphosphates kinase (Buczyński & Potter, 1990 ) EDTA, at the same time, inhibits the synthesis of ACN triphosphates which explains the almost complete loss of inhibitory properties of active ACNs (Table 2) 1 and 2. Active THI derivatives 3, 4 and 5 are not phosphorylated by the enzyme present in the tumour cytosol since they are not substrates for kinases. The OH groups present in the aromatic structure of THI are of acidic character, therefore, they cannot form esters with HPO 4 2-. For this reason EDTA exerts no influence on the inhibitory properties of THI derivatives.
Although the biological activity of modified nucleosides and nucleotides usually results from in vivo phosphorylation of these compounds (Parker et al., 1995; Ilsley et al., 1995; Modrzejewska et al., 1999) some biologically active nucleosides inhibiting HIV-1 are not phosphorylated in vivo (Fossey et al., 1994) . Similarly, alkenophosphonic acid purine and pyrimidine derivatives acting as ACN triphosphate equivalents do not themselves undergo phosphorylation (Harnden et al., 1993) . Active THI derivatives, therefore, should be included among the compounds whose biological activity does not result from phosphorylation.
While commenting on the results included in Table 3 it should be noticed that the CH 2 OH group, preferred by cellular kinases (Daher et al., 1990) which is a component of the 3-hydroxypropyl group of the studied ACNs 1, 2, 6 and 7 (Fig. 1) is a substrate for these enzymes only when it is bound to the position N-1 of the modified pyrimidine base 1 and 2 (Fig. 1) . The above mentioned group present in the 3-hydroxypropyl group bound to N-3 position of modified pyrimidine bases 6 and 7 (Fig. 1) is not recognized by cellular kinases. This explains the very low phosphorylation of ACN derivatives 6 and 7 and, as a consequence, the almost complete lack of inhibitory activity of these compounds (Table 2 and 3). Vol. 50 Acyclonucleosides and 1,2,3,4-tetrahydroisoquinoline derivativesActive ACNs and THIs decrease the synthesis of dTTP and dGTP in the acid soluble fraction of both tumours (Table 3 , ACN derivatives: 41.5 ± 5.2%, THI derivatives: 47.2 ± 3.7% of synthesis inhibition, respectively). In the case of THI this concerns only these derivatives which inhibit the activity of dThd and dCyd kinases in the cytosol of neurofibrosarcoma. The THI derivatives without such activity have no influence on the content of dTTP and dGTP in the acid soluble fraction of both tumours. ).
The active ACNs (alone or in presence of 10 mM EDTA) and THIs were incubated per 1 h with the cytosol obtained from tumours in the presence of 10 mM [g-32 and dGMP synthesis, in the presence of EDTA decrease dTTP and dGTP level by, on average, 48%. This may follow from the fact that EDTA restrains the activity of the deoxynucleoside 5¢-diphosphate kinase but not inhibition of phosphorylation of THI as these compounds are not phosphorylated by the enzyme present in the tumour homogenate. This finding is also confirmed by the fact that EDTA inhibits the synthesis of dTTP and dGTP to the same degree in the presence of biologically inactive THI. In previous studies on uracil ACN derivatives it was proved that uracil alliloxymethyl derivatives, beside moderating the synthesis of DNA precursors, inhibit the in vivo incorporation of labeled dN into DNA obtained from experimental tumours (Greger & Dramiński, 1989; Modrzejewska et al., 1996; 1999) . Similar studies which were carried out on ACNs and THIs demonstrated that these compounds possess similar inhibitory properties. The results of these experiments (Table  5) The inhibition of the activity of dThd and dCyd kinases by uracil ACN derivatives, i.e. inhibition of pyrimidine nucleoside kinases by pyrimidine acyclonucleosides might have been expected. It is not surprising that THI derivatives reveal similar properties as being benzene rings condensed with tertahydropyridine they are formally similar to the ACN
